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SUMMARY – Astrocytoma is the second most common intramedullary tumor of predominantly 
low-grade malignancy in adult patients. Adult astrocytomas have better-quality prognosis compared 
with astrocytomas in children. Although a standardized surgical management protocol for spinal cord 
glioma is currently unavailable, surgery of low-grade astrocytoma should be aimed at gross total resec-
tion to preserve neurological function and to improve the outcome. Herein, we present a personal case 
series of four consecutive adult spinal cord astrocytoma patients who were operated on during the last 
few years. Tumor resection was performed in all patients utilizing microsurgical technique and intra-
operative neurophysiologic monitoring. We also provide a literature review of the treatment of intra-
medullary astrocytoma in adults and discuss contemporary surgical management and prognosis.
Key words: Intramedullary tumor; Low-grade astrocytoma; Microsurgical management
Correspondence to: Kenan Arnautovic, MD, PhD, 6325 Humphreys 
Blvd, Memphis, TN 38120, US
E-mail: kenanarnaut@yahoo.com
Received April 23, 2020, accepted August 28, 2020
Introduction
Spinal cord astrocytoma is an intradural intramed-
ullary glial cell tumor accounting for 6%-8% of all 
 primary spinal cord growths1-5. It is the most common 
intramedullary pediatric tumor and occurs secondary 
to ependymoma in adult patients. Adult astrocytomas 
have better-quality prognosis compared with astrocy-
tomas in children. Although classified as histologically 
malignant according to the 2016 World Health Orga-
nization (WHO) tumor classification6, these tumors 
are predominantly of low-grade malignancy, including 
diffuse and pilocytic astrocytoma1-5. Since the average 
age at presentation in adults is 29±18 years7, it can be 
said that it predominantly affects younger patients, but 
steady age distribution from early childhood to the ad-
vanced age is not rare7. In general, low-grade astrocy-
toma has longer disease history with a range of various 
symptoms that are reliant on tumor volume and loca-
tion, growth pattern, and histology8.
Notwithstanding their low-grade histologic nature, 
these tumors can be well enhanced on contrast mag-
netic resonance imaging (MRI) of the spine2, which 
improves distinction between more common solid and 
less common cystic types of the tumor, which are usu-
ally more malignant4 but can be better gross totally 
resected due to their less infiltrative growth pattern9. 
Nevertheless, a standardized surgical management 
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protocol for spinal cord glioma is currently unavail-
able4,10,11, although the treatment of low-grade tumors 
should be aimed at radical, gross total microsurgical 
resection to improve and preserve neurological func-
tion2,8,12.
Herein, we present a personal surgical case series of 
four spinal cord astrocytoma adult patients, and de-
scribe contemporary microsurgical techniques that are 
intended to assure complete tumor resection. We also 
provide a literature review and discuss the extent of 
resection, neurological outcome, and prognosis.
Case Series Report
During the last few years, four consecutive adult 
spinal cord astrocytoma patients were operated on by a 
senior neurosurgeon (K.I.A.). This personal series of 
surgical patients included three females and one male, 
mean age 55.5 years at the time of surgery. Immediate 
postoperative recovery was favorable in all patients, 
whose neurological and functional status much im-
proved following surgery.
Case 1
A 61-year-old female presented with type 2 diabe-
tes, diabetic polyneuropathy, and gait disturbances 
with minor motor weakness in her lower limbs (light 
paraparesis). She was previously diagnosed with an in-
tramedullary tumor mass at the T1 level and was clin-
ically and radiologically followed-up for several years. 
Her preoperative cervical and thoracic spine contrast-
enhanced magnetic resonance imaging (MRI) at 8 
years, 2 years, and immediately prior to surgery are de-
picted in Figures 1 and 2.
Due to worsening of neurological deficit related to 
tumor progression, she was eventually operated on. 
Fig. 1. Sagittal T2-weighted magnetic resonance imaging (MRI) of the thoracic spine (A) 
showing the hyperintense intramedullary lesion at T1 (arrow); axial T2-weighted MRI of 
the thoracic spine showing lesion at the same level (arrow) (B); sagittal (C) and axial (D) 
T2-weighted MRI of the thoracic spine at 6-year follow-up revealing lesion growth (arrow).
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The tumor was completely resected and histopatho-
logic analysis of tissue samples confirmed the tumor as 
a low-grade astrocytoma (WHO grade II). Postopera-
tive MRI of the cervicothoracic spine showed com-
plete tumor resection (Fig. 2A-H).
Case 2
A 45-year-old female presented with lower back 
pain, decreased motor strength of lower limbs, and 
perineal numbness. Sagittal and axial MRI reforma-
tions of the entire spine showed an intramedullary tu-
mor growth at the T12-L1 levels (Fig. 3A-D). The 
tumor was resected using a meticulous microsurgical 
technique and intraoperative neurophysiological mon-
itoring to record motor evoked potentials (MEP). The 
immediate postoperative imaging of the lumbar and 
thoracic spine are depicted in Figure 4(A-C). Histo-
pathologic diagnosis defined the tumor as anaplastic 
Fig. 2. Preoperative sagittal T2-weighted (A), sagittal T1-weighted post-contrast (B), axial T2-weighted (C), and 
post-contrast axial T1-weighted (D) magnetic resonance imaging (MRI) of the cervicothoracic spine showing an 
intramedullary tumor (arrows); postoperative sagittal T2-weighted (E), sagittal T1-weighted post-contrast (F), axial 
T2-weighted (G), and axial T1-weighted post-contrast (H) MRI of the cervicothoracic spine demonstrating complete 
tumor resection (arrows).
Fig. 3. Sagittal T1-weighted post-contrast magnetic resonance imaging (MRI) of the lumbar spine showing  
well-demarcated homogeneously enhanced intramedullary lesion (arrow) (A); sagittal T2-weighted (B),  
sagittal T2-weighted (C), and axial post-contrast T1-weighted MRI (D) of the lumbar and thoracic spine  
depicting intramedullary tumor at T12 level (arrows).
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astrocytoma (WHO grade III). Postoperative focal 
 irradiation of the tumor field was applied.
Case 3
A 58-year-old male presented with lower limb mo-
tor weakness and sensory loss at the T1 level. Whole 
spine MRI identified an intramedullary tumor growth 
at the T1-2 level (Fig. 5A-C), which was successfully 
resected by microsurgical technique with the help of 
intraoperative neurophysiological monitoring (Fig. 
5D-F). Histopathologic diagnosis confirmed it as low-
grade astrocytoma (WHO grade II).
Case 4
A 58-year-old female presented with lower limb 
motor weakness (paraparesis). Preoperative contrast-
enhancing spinal MRI showed an intramedullary tu-
mor at the T4 level (Fig. 6A-D). Gross total tumor mi-
crosurgical resection was achieved, which was confirmed 
by postoperative MRI of the thoracic spine (Fig. 7A-C). 
Histopathologic diagnosis identified the tumor as low-
grade spinal cord astrocytoma (WHO grade II).
Discussion
After reviewing the literature, we found the mean 
patient age at presentation to range from 28.3 to 41±17 
years7,12,13. Five-year survival of patients with low-
grade tumors (WHO grades I and II) ranged from 
54% to 78% with median survival of 8-13 years. A de-
tailed literature review of spinal cord astrocytomas has 
been published recently by our group8.
Preoperative neuroradiological evaluation includes 
MRI with and without contrast of the selected areas of 
the spine. Enhancement of spinal cord astrocytomas 
appears to vary and may include cystic formations 
within. Anteroposterior/lateral and flexion and exten-
sion x-rays are important to assess the potential spinal 
instability and the need of instrumentation.
Laminectomy with the patient in prone position is 
the most common surgical approach used to expose 
the posterior/dorsal part of the vertebral canal, spinal 
cord, and intramedullary lesions. Laminoplasty can 
also be utilized, especially in younger patients and in 
patients with multiple levels of involvement. Instru-
mented fusion can be considered especially in cervico-
thoracic and thoracolumbar junctions. Dura opening, 
arachnoid dissection, and myelotomy are usually per-
formed dorsally through a midline incision via the 
posterior midline septum. The aim of surgery is to 
separate tumor margins meticulously from the sur-
rounding cord tissue, which is not always easy to 
achieve when infiltrating tumors of more malignant 
grades are encountered8,14. Yet, sharp dissection and 
creation of clear tumor planes is necessary to better 
expose the tumor, but may be challenging, which calls 
for high surgical skills.
We follow these rules for microsurgical technique 
and employed the same operative technique in the pa-
tients from this series8,14. Recently, we have published a 
video clip of the surgical removal of spinal cord astro-
cytoma, which is available with free access14.
Fig. 4. Postoperative T1-weighted post-contrast sagittal magnetic resonance imaging (MRI) of the lumbar (A) and 
thoracic (B) spine showing complete tumor resection; axial T2-weighted MRI of the resection cavity at T12 level (C).
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Recent analyses have shown that intraoperative 
neurophysiological monitoring and computed tomog-
raphy neuro-navigation with advanced multi-modal 
options of microscope-based augmented reality, as well 
as other up-to-date, cutting-edge microsurgical arma-
mentarium may be very helpful in providing accurate 
Fig. 5. Sagittal T2-weighted (A), sagittal post-contrast T1-weighted (B), axial T2-weighted 
magnetic resonance imaging (MRI) (C), sagittal T2-weighted (D), and sagittal post-contrast 
T1-weighted (E) MRI of the thoracic spine showing complete resection of intramedullary 
tumor; axial T2-weighted spinal MRI showing tumor resection cavity (F) (arrows).
Fig. 6. Preoperative sagittal magnetic resonance imaging (MRI) of the spine showing T2-weighted hyperintense  
(A, B) intramedullary contrast-enhancing tumor at T4 level (C) (arrows); axial T2-weighted MRI at the level  
of the tumor (D) (arrow).
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tumor visualization and in ensuring high-precision 
dissection when intradural spinal growths are con-
cerned15,16. In spite of that, literature data on gross tu-
mor resection rates for low-grade spinal cord glioma 
range between 5% and 72.7% of cases13,17-20, although 
population-based studies confirmed improved out-
comes and overall survival in these patients21-25, espe-
cially those of younger age26,27. However, preoperative 
and postoperative neurological condition, extent of 
resection, and low histological grade remain the stron-
gest outcome predictors3,4,8,10,22 28-32.
Gross total tumor resection was achieved in all four 
patients in our series. Their immediate postoperative 
recovery was favorable, which allowed for marked im-
provement in neurological functioning in all of them. 
Nonetheless, having in mind that a significant per-
centage of low-grade astrocytomas are more likely to 
be removed completely, it seems that the extent of re-
section alone may not be the only predictive outcome 
parameter4,8.
Since the postoperative recurrence rate of low-
grade astrocytoma is usually low, it appears that adju-
vant therapy is not obligatory in all cases. Accordingly, 
some authors recommend radiotherapy for patients 
with high-grade tumors only7. We have opted for the 
same strategy in this series of patients, bearing in mind 
that the main factor influencing prognosis and out-
come of these, as well as other primary intramedullary 
spinal cord tumors is not the mode of treatment, but 
tumor grading, preoperative and postoperative neuro-
logical condition, and the extent of resection28,33,34.
In conclusion, we believe that surgery of adult low-
grade spinal cord astrocytoma should be aimed at gross 
total tumor resection in cautiously selected patients, 
which could result in a favorable outcome. Simultane-
ously, cutting-edge microsurgical equipment and tech-
nique should be engaged to achieve the goals of sur-
gery. Neurophysiological monitoring during surgery is 
of utmost importance.
Nonetheless, continuous supplementary research 
in a greater number of patients is required in order to 
endorse these suggestions further.
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Sažetak
ASTROCITOM KRALJEŽNIČKE MOŽDINE NISKOG STUPNJA MALIGNOSTI U ODRASLIH:  
PRIKAZ OSOBNE SERIJE BOLESNIKA I PREGLED LITERATURE
M. Pojskić, K. Rotim, B. Splavski i K.I. Arnautović
Astrocitom kralježničke moždine je tumor pretežito niskog stupnja malignosti koji je po učestalosti drugi intramedular-
ni tumor u odraslih u kojih je njegova prognoza znatno povoljnija u usporedbi s prognozom u djece. Unatoč tomu što stan-
dardizirani protokol za kirurško liječenje gliomskih tumora kralježničke moždine zasad ne postoji, cilj ovakvog liječenja 
trebao bi biti usmjeren ka uklanjanju tumora u cijelosti kako bi se očuvala neurološka funkcionalnost i poboljšala uspješnost 
liječenja. U ovom radu dajemo prikaz osobne serije tijekom nekoliko posljednjih godina susljedno operiranih četvero odraslih 
bolesnika s astrocitomom kralježničke moždine u kojih je tumor mikrokirurški uklonjen uz pomoć intraoperacijskog neuro-
fiziološkog praćenja. U radu također donosimo pregled literature o liječenju intramedularnih astrocitoma u odraslih, rasprav-
ljajući o suvremenom kirurškom liječenju ovakvih tumora i prognozi bolesti.
Ključne riječi: Intramedularni tumor; Astrocitom, niski stupanj malignosti; Mikrokirurško liječenje
